Medicines List

Select category
  • The product has not yet been released on the market.

    Description

    Vale contains two different substances called sacubitril and valsartan. It is a medicine known as an angiotensin receptor neprilysin inhibitor.
    Vale is used to treat a certain type of chronic heart failure in adults, children, and adolescents.
    This type of heart failure occurs when the heart is weak and cannot pump enough blood to the lungs and the rest of the body. The most common symptoms of heart failure are breathlessness, fatigue, tiredness and ankle swelling.

    Indications

    Vale is used to treat symptomatic chronic heart failure:

    • in adults with reduced ejection fraction;
    • in children and adolescents (one year and older) with left ventricular systolic dysfunction.

     Subject to medical prescription.

     Concentration and pharmaceutical form: 24 mg/26 mg; 49 mg/51 mg; 97 mg/103 mg film-coated tablets

  • The product has not yet been released on the market.

    Description

    Famore contains the active substance famotidine, which belongs to a group of medicines called H2-blockers, which work by reducing the amount of acid produced in the stomach and thus helping to improve the condition.

    Indications

    For the treatment of the following diseases and conditions in which a reduction in gastric acid secretion is indicated:

    • duodenal ulcer;
    • benign gastric ulcer;
    • symptoms caused by reflux of gastric juice into the oesophagus;
    • other hypersecretory conditions (e.g. Zollinger-Ellison syndrome).

    Subject to medical prescription.

    Concentration and pharmaceutical form: 20 mg; 40 mg film-coated tablets

  • The product has not yet been released on the market.

    Description

    Dapagliflozin Tchaikapharma contains the active substance dapagliflozin. It belongs to a group of medicines called “sodium glucose co-transporter-2 (SGLT2) inhibitors”. They work by blocking the SGLT2 protein in your kidney. By blocking this protein, blood sugar (glucose), salt (sodium) and water are removed from your body via the urine.

    Indications

    Dapagliflozin Tchaikapharma is used:

    • in adults and children for the treatment of type 2 diabetes mellitus as an adjunct to diet and physical activity:
    • as monotherapy when the use of metformin is considered inappropriate due to intolerance;
    • as an add-on to other medicinal products for the treatment of type 2 diabetes mellitus;
    • in adults for the treatment of symptomatic chronic heart failure;
    • in adults for the treatment of chronic kidney disease.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 10 mg film-coated tablets

  • The product has not yet been released on the market.

    Description

    Dapagliflozin/Metformin Tchaikapharma contains two different substances called dapagliflozin and metformin. Both belong to a group of medicines called “oral anti-diabetics”. These are medicines taken by mouth to treat diabetes.

    Dapagliflozin/Metformin Tchaikapharma is used for a type of diabetes called “type 2 diabetes” in adult patients (aged 18 years and older) and usually occurs when you are older. If you have type 2 diabetes, your pancreas does not produce enough insulin or your body is not able to use the insulin it produces properly. This leads to a high level of sugar (glucose) in your blood.

    • Dapagliflozin works by removing excess sugar from your body via your urine and lowers the amount of sugar in your blood. It can also help prevent heart disease.
    • Metformin works mainly by inhibiting glucose production in the liver.

    Indications

    Dapagliflozin/Metformin Tchaikapharma is indicated in adults for the treatment of type 2 diabetes mellitus as an adjunct to diet and exercise:

    • in patients insufficiently controlled on their maximally tolerated dose of metformin alone;
    • in combination with other medicinal products for the treatment of diabetes in patients insufficiently controlled with metformin and these medicinal products;
    • in patients already being treated with the combination of dapagliflozin and metformin as separate tablets.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 5 mg /850 mg; 5 mg /1000 mg film-coated tablets